Patient information: uses, side effects, how to take - Tivicay Tablet 50 mg
What is TIVICAY and TIVICAY PD?
TIVICAY and TIVICAY PD are prescription medicines used to treat Human Immunodeficiency Virus-1 (HIV-1) infection together with:
- other HIV-1 medicines in adults who have not received HIV-1 medicines in the past or to replace their current HIV-1 medicines.
- other HIV-1 medicines in children, aged at least 4 weeks and weighing at least 6.6 pounds (3 kg), who have not received HIV-1 medicines in the past or to replace their current HIV-1 medicines when their healthcare provider determines that they meet certain requirements.
TIVICAY is used together with rilpivirine as a complete regimen to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults to replace their current HIV-1 medicines when their healthcare provider determines that they meet certain requirements.
HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS).
It is not known if TIVICAY or TIVICAY PD is safe and effective in children who are less than 4 weeks of age and weigh less than 6.6 pounds (3 kg) or in children who have received certain types of medicine for HIV-1 infection.
Do not take TIVICAY or TIVICAY PD if you:
- have ever had an allergic reaction to a medicine that contains dolutegravir.
- take dofetilide.
Before you take TIVICAY or TIVICAY PD, tell your healthcare provider about all of your medical conditions, including if you:
- have or have had liver problems, including hepatitis B or C infection.
are pregnant or plan to become pregnant. Talk to your healthcare provider about the benefits and risks of treatment with TIVICAY or TIVICAY PD during pregnancy.
Pregnancy Registry.There is a pregnancy registry for those who take TIVICAY or TIVICAY PD during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. Talk with your healthcare provider about how you can take part in this registry.
are breastfeeding or plan to breastfeed. TIVICAY and TIVICAY PD pass to your baby in your breast milk. Talk with your healthcare provider about the following risks to your baby from breastfeeding during treatment with TIVICAY and TIVICAY PD:
- the HIV-1 virus may pass to your baby if your baby does not have HIV-1 infection.
- the HIV-1 virus may become harder to treat if your baby has HIV-1 infection.
- your baby may get side effects from TIVICAY.
Tell your healthcare provider about all the medicines you take,including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Some medicines interact with TIVICAY or TIVICAY PD. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.
- You can ask your healthcare provider or pharmacist for a list of medicines that interact with TIVICAY or TIVICAY PD.
- Do not start taking a new medicine without telling your healthcare provider.Your healthcare provider can tell you if it is safe to take TIVICAY or TIVICAY PD with other medicines.
How should I take TIVICAY or TIVICAY PD?
- Take TIVICAY or TIVICAY PD exactly as your healthcare provider tells you to take it.
Take TIVICAY or TIVICAY PD with or without food.
- For children who cannot swallow tablets, read the Instructions for Use at the end of this patient information for detailed instructions on how to prepare a dose of TIVICAY PD tablets for oral suspension.
- TIVICAY PD may be swallowed whole or dispersed in drinking water and should not be chewed, cut, or crushed.
- TIVICAY tablets are not the same as TIVICAY PD tablets for oral suspension and cannot be substituted for each other. Check to make sure you receive the correct form of TIVICAY each time you or your child’s prescription is filled to avoid using the wrong medicine.
- Do not change your dose, switch medicines or stop taking TIVICAY or TIVICAY PD without talking with your healthcare provider first.
- If you take antacids, laxatives, or other medicines that contain aluminum, magnesium, or buffered medicines, TIVICAY or TIVICAY PD should be taken at least 2 hours before or 6 hours after you take these medicines.
If you need to take iron or calcium supplements by mouth during treatment with TIVICAY or TIVICAY PD:
- If you take TIVICAY with food, you may take these supplements at the same time that you take TIVICAY.
- If you do not take TIVICAY or TIVICAY PD with food, take TIVICAY or TIVICAY PD at least 2 hours before or 6 hours after you take these supplements.
- Do not miss a dose of TIVICAY or TIVICAY PD.
- If you miss a dose of TIVICAY or TIVICAY PD, take it as soon as you remember. Do not take 2 doses at the same time or take more than your prescribed dose.
- Stay under the care of a healthcare provider during treatment with TIVICAY or TIVICAY PD.
- Do not run out of TIVICAY or TIVICAY PD. The virus in your blood may increase and the virus may become harder to treat. When your supply starts to run low, get more from your healthcare provider or pharmacy.
- If you take too much TIVICAY or TIVICAY PD, call your healthcare provider or go to the nearest hospital emergency room right away.
What are the possible side effects of TIVICAY or TIVICAY PD?
- TIVICAY or TIVICAY PD can cause serious side effects including:
- Allergic reactions.Call your healthcare provider right away if you develop a rash with TIVICAY or TIVICAY PD. Stop taking TIVICAY or TIVICAY PD and get medical help right away if you develop a rash with any of the following signs or symptoms:
- fever
- generally ill feeling
- tiredness
- muscle or joint aches
- blisters or sores in mouth
- blisters or peeling of the skin
- redness or swelling of the eyes
- swelling of the mouth, face, lips, or tongue
- problems breathing
- Liver problems.People with a history of hepatitis B or C virus may have an increased risk of developing new or worsening changes in certain liver tests during treatment with TIVICAY or TIVICAY PD. Liver problems, including liver failure, have also happened in people without a history of liver disease or other risk factors. Your healthcare provider may do blood tests to check your liver. Call your healthcare provider right away if you develop any of the following signs or symptoms of liver problems:
- your skin or the white part of your eyes turns yellow (jaundice)
- dark or “tea-colored” urine
- light-colored stools (bowel movements)
- nausea or vomiting
- loss of appetite
- pain, aching, or tenderness on the right side of your stomach area
- Changes in your immune system (Immune Reconstitution Syndrome)can happen when you start taking HIV-1 medicines. Your immune system may get stronger and begin to fight infections that have been hidden in your body for a long time. Tell your healthcare provider right away if you start having new symptoms after you start taking TIVICAY or TIVICAY PD.
- The most common side effects of TIVICAY include:
- trouble sleeping
- tiredness
- headache
These are not all the possible side effects of TIVICAY or TIVICAY PD. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1‑800‑FDA‑1088.
How should I store TIVICAY or TIVICAY PD?
- Store TIVICAY 10-mg, 25-mg, and 50-mg tablets at room temperature between 68°F to 77°F (20°C to 25°C).
- Store TIVICAY 10-mg tablets in the original bottle. Keep the bottle tightly closed and protected from moisture. The bottle contains a desiccant packet to help keep your medicine dry (protect it from moisture). Do not remove the desiccant packet from the bottle.
- Store TIVICAY PD 5-mg tablets for oral suspension at room temperature below 86°F (30°C) in the original bottle. Keep the bottle tightly closed and protected from moisture. The bottle contains a desiccant packet to help keep your medicine dry (protect it from moisture). Do not remove the desiccant packet from the bottle.
Keep TIVICAY, TIVICAY PD, and all medicines out of the reach of children.
General information about the safe and effective use of TIVICAY or TIVICAY PD.
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use TIVICAY or TIVICAY PD for a condition for which it was not prescribed. Do not give TIVICAY or TIVICAY PD to other people, even if they have the same symptoms you have. It may harm them. You can ask your healthcare provider or pharmacist for information about TIVICAY that is written for health professionals.
What are the ingredients in TIVICAY and TIVICAY PD?
Active ingredient:dolutegravir.
Inactive ingredients:
TIVICAY tablets: D-mannitol, microcrystalline cellulose, povidone K29/32, sodium starch glycolate, and sodium stearyl fumarate. The tablet film‑coating contains the inactive ingredients iron oxide yellow (for the 25-mg and 50-mg tablets only), macrogol/PEG, polyvinyl alcohol-part hydrolyzed, talc, and titanium dioxide.
TIVICAY PD tablets for oral suspension: calcium sulfate dihydrate, crospovidone, mannitol, microcrystalline cellulose, povidone K29/32, silicified microcrystalline cellulose, sodium starch glycolate, strawberry cream flavor, sucralose, and sodium stearyl fumarate. The tablet film-coating contains hypromellose, polyethylene glycol, and titanium dioxide.
Manufactured for:
ViiV Healthcare
Durham, NC 27701
TIVICAY and TIVICAY PD are trademarks owned by or licensed to the ViiV Healthcare group of companies.
©2024 ViiV Healthcare group of companies or its licensor.
TVC:14PIL
For more information, go to www.TIVICAY.comor call 1-877-844-8872.
This Patient Information has been approved by the U.S. Food and Drug Administration.
Revised: 4/2024
| INSTRUCTIONS FOR USE | |
TIVICAY PD (TIV-eh-kay Pe De) (dolutegravir) tablets for oral suspension 5 mg | |
Read this Instructions for Use before giving a dose of medicine. Follow the steps below, using clean drinking water to prepare and give a dose to an infant or a child who cannot swallow the tablets. Important information Always give this medicine exactly as your healthcare provider tells you. Talk to your healthcare provider if you are not sure. Do notchew, cut, or crush the tablets. If you forget to give a dose of medicine, give it as soon as you remember. Do not give 2 doses at the same time or give more than your healthcare provider has prescribed. If your child does not or cannot take the full dose, call your healthcare provider. If you give too much medicine, get emergency medical help right away. If your child is able and prefers to swallow the tablets, then you may skip the following steps. | |
| Your pack contains: | |
![]() |
|
You will also need:
| |
Getting Ready Step 1. Pour water | |
![]() Figure A |
Use drinking water only. Do notuse any other drink or food to prepare the dose. |
| Step 2. Prepare the medicine | |
![]() Figure B Figure C |
|
If you spill any medicine, clean up the spill. Throw away the rest of the prepared medicine and make a new dose. You must give the dose of medicine within 30 minutes of preparing the dose.If it has been more than 30 minutes, wash away all the dose in the cup using water and prepare a new dose of medicine. | |
Giving the medicine Step 3. Give the medicine | |
![]() Figure D |
|
![]() Figure E Figure F |
Allow time for the medicine to be swallowed . |
Cleaning Step 4. Clean the dosing items | |
![]() Figure G Figure H |
|
Storage Information Store TIVICAY PD tablets for oral suspension at room temperature below 86°F (30°C) in the original bottle. Keep the bottle tightly closed and protect from moisture. The bottle contains a desiccant packet to help keep your medicine dry (protect it from moisture). Do not remove the desiccant packet from the bottle. Keep TIVICAY PD and all medicines out of the reach of children. | |
Disposal Information When all the tablets in the bottle have been taken or are no longer needed, throw away the bottle, cup, and syringe. Dispose of them using your local household waste guidelines. You will get a new cup and syringe in your next pack. | |
Manufactured for: ViiV Healthcare Durham, NC 27701 | |
Trademarks are owned by or licensed to the ViiV Healthcare group of companies. ©2024 ViiV Healthcare group of companies or its licensor. TVC: 3IFU | |
| This Instructions for Use has been approved by the U.S. Food and Drug Administration. | Revised: 4/2024 |






